INNO-GENE SA ZY -10 (WQ3) — Cash Flow Quality Index
INNO-GENE SA ZY -10 (WQ3) has a Cash Flow Quality Index of 0.05x as of December 2024. Operating cash flow of €147.00K is below net income of €2.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore WQ3 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
INNO-GENE SA ZY -10 Cash Flow Quality Index (2021–2024)
Historical Cash Flow Quality Index for INNO-GENE SA ZY -10 across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check WQ3 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for INNO-GENE SA ZY -10 (2021–2024)
Year-by-year earnings quality comparison for INNO-GENE SA ZY -10. For live market cap and the full company financial profile, see WQ3 stock market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -60.00x | €-1.13 Million | €18.85K | ▼ -171907.8% |
| 2022 | 0.03x | €11.00K | €315.00K | ▼ -96.9% |
| 2021 | 1.12x | €6.75 Million | €6.03 Million | — |